Updated Jul 16, 2026 · Last SEC filing 2026-07-09
Immunome Inc. (IMNM) has filed 14 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-09. 2 Form 8-K material event filings were reported by IMNM in the last 90 days. 8 Form 144 notices of proposed sale were filed for IMNM stock. InsiderAlpha tracks every IMNM SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001472012 |
|---|
| Form 4 filings (90d) | 14 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Form 144 notices (90d) | 8 |
| Latest Form 4 filing | 2026-07-09 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Horn Kinney | CHIEF BUSINESS OFFICER | M — Option exercise | 1.1K | $12.92 | $14K | SEC | |
| Barchas Isaac | Insider | S — Open-market sale | 16.9K | $24.20 | $409K | SEC | |
| Horn Kinney | CHIEF BUSINESS OFFICER | S — Open-market sale | 1.1K | $25.00 | $27K | SEC | |
| Barchas Isaac | Insider | S — Open-market sale | 83.1K | $24.11 | $2.00M | SEC | |
| Barchas Isaac | Insider | S — Open-market sale | 75.7K | $22.35 | $1.69M | SEC | |
| Barchas Isaac | Insider | S — Open-market sale | 24.3K | $23.33 | $568K | SEC | |
| Lechleider Robert | Chief Medical Officer | S — Open-market sale | 16.2K | $22.76 | $369K | SEC | |
| Lechleider Robert | Chief Medical Officer | M — Option exercise | 55.0K | $8.73 | $480K | SEC | |
| Lechleider Robert | Chief Medical Officer | S — Open-market sale | 22.7K | $21.95 | $499K | SEC | |
| Lechleider Robert | Chief Medical Officer | S — Open-market sale | 16.1K | $23.44 | $377K | SEC | |
| Barchas Isaac | Insider | S — Open-market sale | 101.0K | $21.12 | $2.13M | SEC | |
| Lechleider Robert | Chief Medical Officer | M — Option exercise | 55.0K | $8.73 | $480K | SEC | |
| Lechleider Robert | Chief Medical Officer | S — Open-market sale | 14.4K | $20.66 | $298K | SEC | |
| Lechleider Robert | Chief Medical Officer | S — Open-market sale | 40.6K | $19.56 | $794K | SEC | |
| Rosett Max | Chief Financial Officer | S — Open-market sale | 60.0K | $18.23 | $1.09M | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Immunome Inc. (IMNM). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Lechleider Robert | 9 | $3.30M |
| BIENAIME JEAN JACQUES | 7 | $512K |
| Barchas Isaac | 6 | $6.81M |
| Horn Kinney | 3 | $41K |
| Rosett Max | 3 | $1.16M |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in IMNM insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live IMNM dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.